| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.0051 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0015 | 1 |